LoginRegister
    Regulation of E-Pharmacies: DTAB calls for finalization of rules to regulate online sale, distribution of drugsRegulation of E-Pharmacies: DTAB calls for finalization of rules to regulate online sale,...
    Chemist license suspended for selling MTP pills sans prescriptionChemist license suspended for selling MTP pills sans prescription
    Unichem gets USFDA nod for Solifenacin Succinate tablets to treat overactive bladderUnichem gets USFDA nod for Solifenacin Succinate tablets to treat overactive bladder
    Revised drug law to pave way for cheap Indian generic medicines in China: ReportRevised drug law to pave way for cheap Indian generic medicines in China: Report
    Ipca Labs gets 3 USFDA observations for Silvassa unitIpca Labs gets 3 USFDA observations for Silvassa unit
    AstraZeneca gets USFDA fast track status for development of diabetes drug FarxigaAstraZeneca gets USFDA fast track status for development of diabetes drug Farxiga
    Purdue Pharma offers upto USD 12 billion to settle opioid claimsPurdue Pharma offers upto USD 12 billion to settle opioid claims
    CDSCO committee recommends exemption of chemical contraceptive FDC from Schedule H; DetailsCDSCO committee recommends exemption of chemical contraceptive FDC from Schedule H; Details
    Indian Stent Maker Translumina sells stake to PE Everstone for Rs 500 crore: ReportIndian Stent Maker Translumina sells stake to PE Everstone for Rs 500 crore: Report
    Strides Pharma acquires manufacturing plant in Florida for Rs 3.59 croreStrides Pharma acquires manufacturing plant in Florida for Rs 3.59 crore
    Lupin inks commercial pact with Creso Pharma for cannaQIXLupin inks commercial pact with Creso Pharma for cannaQIX
    SastaSundar Healthbuddy, Mitsubishi Corp sign deal worth Rs 100 crore for affordable healthcareSastaSundar Healthbuddy, Mitsubishi Corp sign deal worth Rs 100 crore for affordable healthcare
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X